Form 4 for PMVP PMV Pharmaceuticals, Inc.
Accepted 2025-01-22 00:00:00 ET · period of report 2024-12-03 · accession 0001415889-25-001853 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-01-22 | 2024-12-03+ | PMVP | Mack David Henry | Pres, CEO, Dir | M - OptEx | $0.53 | +109.5K | 551.9K | +25% | +$58.0K |
| DM | 2025-01-22 | 2024-12-03+ | PMVP | Mack David Henry | Pres, CEO, Dir | M - OptEx | $0.00 | -109.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-03 | M | A | 91,750 | $0.53 | 534,210 | D | — | — | |
| 2 | Common | Common Stock | 2025-01-03 | M | A | 17,709 | $0.53 | 551,919 | D | — | — | |
| 3 | Derivative | Employee Stock Option (right to buy) | 2024-12-03 | M | D | 91,750 | $0.00 | 17,709 | D | $0.53 · — to 2025-05-11 | 91,750 Common Stock | (F4) The shares subject to the option are fully vested and immediately exercisable. |
| 4 | Derivative | Employee Stock Option (right to buy) | 2025-01-03 | M | D | 17,709 | $0.00 | 0 | D | $0.53 · — to 2025-05-11 | 17,709 Common Stock | (F4) The shares subject to the option are fully vested and immediately exercisable. |